JYNT

The Joint Corp. [JYNT] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

JYNT Stock Summary

Top 10 Correlated ETFs

JYNT


Top 10 Correlated Stocks

JYNT


In the News

02:17 29 Sep 2023 JYNT

The Joint (JYNT) Forays Into West Virginia Chiropractic Market

The Joint's (JYNT) new facility is positioned near the West Virginia University campus, at a high-traffic shopping center.

02:16 29 Sep 2023 JYNT

The Joint (JYNT) Q2 Earnings Miss Estimates, 2023 View Down

The Joint (JYNT) expects to open 100-120 franchised clinics in 2023 compared with 121 opened last year.

06:47 29 Sep 2023 JYNT

The Joint Corp. (JYNT) Reports Q2 Loss, Misses Revenue Estimates

The Joint Corp. (JYNT) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of $0.03. This compares to earnings of $0.02 per share a year ago.

07:05 29 Sep 2023 JYNT

The Joint Corp. to Participate in Upcoming Conferences

SCOTTSDALE, Ariz., Sept. 06, 2023 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, announced that management plans to participate in and conduct one-on-one meetings at these upcoming conferences.

11:40 29 Sep 2023 JYNT

The Joint Corp. (JYNT) Q2 2023 Earnings Call Transcript

The Joint Corp. (NASDAQ:JYNT ) Q2 2023 Earnings Conference Call August 10, 2023 5:00 PM ET Company Participants Kirsten Chapman - Investor Relations Peter Holt - President and Chief Executive Officer Jake Singleton - Chief Financial Officer Conference Call Participants Jeremy Hamblin - Craig-Hallum Capital Group Jeff Van Sinderen - B. Riley Thomas McGovern - Maxim Group George Kelly - ROTH MKM Operator Hello, and welcome to The Joint Corp. Second Quarter 2023 Financial Results Conference Call.

12:10 29 Sep 2023 JYNT

The Joint (JYNT) Reaches 900th Clinic Mark With New Texas Unit

The Joint (JYNT) moves from the 800th to the 900th clinic milestone in less than a year.

07:05 29 Sep 2023 JYNT

The Joint Corp. to Host Conference Call on Thursday, August 10th to Discuss Second Quarter 2023 Results

SCOTTSDALE, Ariz., July 13, 2023 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic ® network, announced it will report its second quarter 2023 financial results on Thursday, August 10, 2023, after the market close. President and CEO Peter D. Holt and CFO Jake Singleton will hold a conference call at 5:00 p.m. EDT that day to discuss the results.

09:34 29 Sep 2023 JYNT

The Joint (JYNT) Buys Wisconsin Regional Developer Zone Rights

The Joint (JYNT) expects the Wisconsin region to hold a total of 53 clinics, of which 21 are currently operating.

11:35 29 Sep 2023 JYNT

The Joint Corp. (JYNT) Surges 10.0%: Is This an Indication of Further Gains?

The Joint Corp. (JYNT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

07:05 29 Sep 2023 JYNT

The Joint Corp. to Participate in Upcoming Conferences

SCOTTSDALE, Ariz., May 15, 2023 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, announced that management plans to participate in and conduct one-on-one meetings at these upcoming conferences.

JYNT Financial details

Company Rating
Strong Buy
Market Cap
142.84M
Income
3.15M
Revenue
112.17M
Book val./share
2.42
Cash/share
0.93
Dividend
-
Dividend %
-
Employees
359
Optionable
No
Shortable
Yes
Earnings
01 Nov 2023
P/E
42.53
Forward P/E
-
PEG
-7.51
P/S
1.2
P/B
3.76
P/C
9.81
P/FCF
11.77
Quick Ratio
0.69
Current Ratio
0.9
Debt / Equity
0.79
LT Debt / Equity
0.62
-
-
EPS (TTM)
0.22
EPS next Y
-
EPS next Q
0.07
EPS this Y
-84%
EPS next Y
-
EPS next 5Y
26.73%
EPS last 5Y
34.02%
Revenue last 5Y
26.24%
Revenue Q/Q
3.01%
EPS Q/Q
-108.13%
-
-
-
-
SMA20
-1.77%
SMA50
-30.2%
SMA100
-39.4%
Inst Own
83.47%
Inst Trans
1%
ROA
3%
ROE
9%
ROC
0.02%
Gross Margin
91%
Oper. Margin
1%
Profit Margin
3%
Payout
4%
Shs Outstand
14.74M
Shs Float
10.53M
-
-
-
-
Target Price
-
52W Range
8.76-20.0
52W High
-54.4%
52W Low
+14%
RSI
35.04
Rel Volume
0.68
Avg Volume
148.51K
Volume
100.6K
Perf Week
-5.59%
Perf Month
-16.56%
Perf Quarter
-42.75%
Perf Half Y
-43.25%
-
-
-
-
Beta
1.44156
-
-
Volatility
0.19%, 0.28%
Prev Close
-1.41%
Price
9.12
Change
-2.25%

JYNT Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
Revenue per share
2.333.514.195.677.03
Net income per share
0.020.240.940.50.08
Operating cash flow per share
0.40.540.81.060.77
Free cash flow per share
0.30.240.50.480.16
Cash per share
0.640.611.471.360.67
Book value per share
0.170.411.482.062.23
Tangible book value per share
-0.16-0.120.951.330.76
Share holders equity per share
0.170.411.482.062.23
Interest debt per share
0.131.031.321.571.86
Market cap
113.73M223.04M367.74M940.64M202.55M
Enterprise value
106.11M228.86M365.66M943.57M218.86M
P/E ratio
449.3767.1127.93131.39172.05
Price to sales ratio
3.584.66.2711.591.99
POCF ratio
20.8629.6532.8861.7518.27
PFCF ratio
27.9966.4452.63137.2387.66
P/B Ratio
48.1638.9917.7231.856.26
PTB ratio
48.1638.9917.7231.856.26
EV to sales
3.344.726.2311.622.15
Enterprise value over EBITDA
36.741.4445.0177.5920.76
EV to operating cash flow
19.4630.4332.761.9419.74
EV to free cash flow
26.1268.1852.33137.6694.72
Earnings yield
00.010.040.010.01
Free cash flow yield
0.040.020.020.010.01
Debt to equity
0.772.50.890.760.8
Debt to assets
0.080.330.280.270.28
Net debt to EBITDA
-2.631.05-0.260.241.55
Current ratio
1.340.981.351.170.76
Interest coverage
00003.04
Income quality
21.542.260.852.139.42
Dividend Yield
00000
Payout ratio
00000.33
Sales general and administrative to revenue
0.640.630.620.610.67
Research and developement to revenue
00000
Intangibles to total assets
0.190.170.110.120.23
Capex to operating cash flow
-0.25-0.55-0.38-0.55-0.79
Capex to revenue
-0.04-0.09-0.07-0.1-0.09
Capex to depreciation
-0.89-2.19-1.53-1.38-1.15
Stock based compensation to revenue
0.020.010.020.010.01
Graham number
0.271.55.64.822.02
ROIC
0.060.10.250.10.02
Return on tangible assets
0.010.090.230.10.02
Graham Net
-0.81-1.95-1.6-2.22-3.17
Working capital
2.97M-262.64K6.45M3.77M-5.5M
Tangible asset value
-2.19M-1.65M13.26M19.07M11.04M
Net current asset value
-9.45M-24.68M-19.85M-27.9M-41.93M
Invested capital
0.772.50.890.760.8
Average receivables
1.34M2.07M2.31M2.62M3.65M
Average payables
1.16M1.39M1.54M1.63M2.34M
Average inventory
668.51K850.26K1.06M1.27M1.62M
Days sales outstanding
15.6520.911.5115.2414.01
Days payables outstanding
106.13100.0687.5973.12110.15
Days of inventory on hand
63.4462.3965.2359.269.04
Receivables turnover
23.3217.4731.7123.9426.06
Payables turnover
3.443.654.174.993.31
Inventory turnover
5.755.855.66.175.29
ROE
0.110.580.630.240.04
Capex per share
-0.1-0.3-0.3-0.59-0.61

Quarterly Fundamentals Overview

Last date of statement is 2023-06-30 for Q2

Metric History 2022-06-302022-09-302022-12-312023-03-31 2023-06-30
Revenue per share
1.731.831.911.952
Net income per share
0.020.030.040.16-0.01
Operating cash flow per share
0.070.290.370.410.1
Free cash flow per share
-0.230.210.250.330
Cash per share
0.650.710.671.010.93
Book value per share
2.12.172.232.412.42
Tangible book value per share
0.920.890.761.011.16
Share holders equity per share
2.12.172.232.412.42
Interest debt per share
1.741.731.811.661.91
Market cap
221.62M228M203.13M245.15M198.23M
Enterprise value
237.25M242.22M219.44M258.29M212.62M
P/E ratio
160.72116.0692.826.63-260.31
Price to sales ratio
8.848.577.38.626.76
POCF ratio
217.8654.0637.640.69134.99
PFCF ratio
-68.0374.5256.4150.81-3.24K
P/B Ratio
7.287.246.276.995.57
PTB ratio
7.287.246.276.995.57
EV to sales
9.479.17.899.087.25
Enterprise value over EBITDA
100.979.6559.59143.8894.77
EV to operating cash flow
233.2257.4340.6242.87144.78
EV to free cash flow
-72.8379.1760.9453.54-3.48K
Earnings yield
0000.010
Free cash flow yield
-0.010.010.020.020
Debt to equity
0.820.780.80.80.79
Debt to assets
0.290.280.280.280.28
Net debt to EBITDA
6.644.684.437.326.41
Current ratio
0.870.870.760.940.9
Interest coverage
3.31.867.410.150
Income quality
2.958.599.872.62-8.89
Dividend Yield
00000
Payout ratio
0000.060
Sales general and administrative to revenue
0.660.670.660.70.68
Research and developement to revenue
00000
Intangibles to total assets
0.20.210.230.210.19
Capex to operating cash flow
-4.2-0.27-0.33-0.2-1.04
Capex to revenue
-0.17-0.04-0.06-0.04-0.05
Capex to depreciation
-2.51-0.58-0.78-0.51-0.69
Stock based compensation to revenue
0.010.010.010.010.01
Graham number
1.061.291.372.930.84
ROIC
0.010.010.0100
Return on tangible assets
00.010.010.030
Graham Net
-2.94-2.93-3.16-3.06-3.16
Working capital
-2.53M-2.72M-5.5M-1.41M-2.41M
Tangible asset value
13.32M12.87M11.04M14.7M17.06M
Net current asset value
-38.05M-37.84M-41.93M-39.39M-41.17M
Invested capital
0.820.780.80.80.79
Average receivables
3.59M3.75M3.93M3.72M3.53M
Average payables
1.72M1.78M2.47M2.4M1.71M
Average inventory
1.9M2.1M1.92M1.82M1.96M
Days sales outstanding
12.7913.3512.6611.1510.86
Days payables outstanding
58.2971.64102.696354.65
Days of inventory on hand
82.5971.2864.3661.4173.62
Receivables turnover
7.046.747.118.078.29
Payables turnover
1.541.260.881.431.65
Inventory turnover
1.091.261.41.471.22
ROE
0.010.020.020.07-0.01
Capex per share
-0.3-0.08-0.12-0.08-0.1

JYNT Frequently Asked Questions

What is The Joint Corp. stock symbol ?

The Joint Corp. is a US stock , located in Scottsdale of Az and trading under the symbol JYNT

What is The Joint Corp. stock quote today ?

The Joint Corp. stock price is $9.12 today.

Is The Joint Corp. stock public?

Yes, The Joint Corp. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap